Stressors during pregnancy (e.g., environmental toxins, diabetes, obesity, inflammation and abnormal placental development and function) impact placental and fetal metabolism. These stressors can alter early fetal development, and are associated with future life risks for the infants: obesity, diabetes and cardiovascular disease. However, clinicians are still unable to identify which pregnancies or infants are at risk, nor are they able to diagnose abnormalities early enough to suggest interventions or therapies that could help prevent future disease from developing.
Our research group will continue to develop and implement novel experimental strategies with the goal of helping physicians to provide the best pregnancy care to women, and a healthy life for their children and future generations.
Research Focus: Maternal cardiovascular and metabolic health, placental function, as well as fetal and infant health.